#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary mediastinal large B-cell lymphoma VEXAS syndrome Mitochondrial myopathy Neovascular age-related macular degeneration Uveitis Metastases to central nervous system Osteosarcoma recurrent Acquired ATTR amyloidosis Pituitary-dependent Cushing's syndrome Asthma Neurofibromatosis Leukoencephalopathy Anti-myelin-associated glycoprotein associated polyneuropathy Albright's disease Deafness More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Life with Disease Rhabdomyosarcoma – Trials in Disease Brain stem glioma – Basic Information Phenylketonuria Erdheim-Chester disease – Treatment Glycogen storage disease type V – Life with Disease Leiomyosarcoma recurrent – Diagnostics Acquired haemophilia – Treatment Waldenstrom’s macroglobulinaemia refractory – Basic Information Hairy cell leukaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vidutolimod SIPAVIBART Pf-06835375 Fenoterol Hydrobromide HTL0022537 Mavorixafor Sodium Citalopram Hydrochloride Tipapkinogene Sovacivec Skin Autograft Risdiplam Ly3556050 ALLERGEN EXTRACTS Hydroxychloroquine Sulfate Cusatuzumab Vericiguat Propranolol Hydrochloride Rigosertib Sodium IMEROPRUBART FRUQUINTINIB More therapies…

    Learn about Your Condition

    Post-traumatic headache Atrial fibrillation Anal squamous cell carcinoma Stevens-Johnson syndrome Alport's syndrome Macular oedema Retinitis pigmentosa Enteritis Venous thrombosis limb Type V hyperlipidaemia Aortic stenosis Paresis Seasonal allergy Mantle cell lymphoma stage II Skin bacterial infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Clopidogrel and Acetylsalicylic Acid for Patients with Coronary Artery Disease and Non-ST-segment Elevation Acute Coronary Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    The Netherlands

  • Study on Dostarlimab and Niraparib for Patients with Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer recurrent
    • Ovarian cancer
    • Endometrial cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Dostarlimab
    France Italy Spain

  • Evaluation of inhaled formoterol fumarate to prevent lung complications after chest cancer surgery in high-risk patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Post procedural complication
    Investigated Drugs:
    • Formoterol Fumarate
    France

  • Study on Personalized vs Non-Personalized Radionuclide Therapy with 177Lu-Edotreotide and Capecitabine for Patients with Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    • Capecitabine
    Sweden

  • Study of Pembrolizumab and Cabozantinib for Patients with Advanced Sarcomas: Undifferentiated Pleomorphic Sarcoma, Osteosarcoma, and Ewing Sarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant fibrous histiocytoma
    • Sarcoma
    • Osteosarcoma
    Investigated Drugs:
    • Cabozantinib
    • Pembrolizumab
    France

  • Study on the Effects of Lenomorelin in Patients with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Lenomorelin
    The Netherlands
Previous Page
1 … 613 614 615 616 617 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!